Article
Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
Journal of pharmacological sciences - 1 Jan 2010
Itokawa Masanari, Arinami Tadao, Toru Michio
Abstract excerpt
Schizophrenia is a debilitating and complex mental disorder with a prevalence of approximately 1% worldwide. The etiology remains unclear, despite massive research efforts. Hyperactive dopaminergic signal transduction in the central nervous system is suggested to be involved in the pathophysiology of schizophrenia (the dopamine hypothesis). The dopamine D(2)-receptor (DRD2) gene is thus a promising candidate for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
